A leading biotechnology company, LS9, Inc. has gathered an investment of $25 million in funding from numerous different investors.  The companies that have decided to help finance LS9’s vision are:  CTTV Investments, the venture capital division of Chevron Technology Ventures; Khosla Ventures, Lightspeed Venture Partners; and Flagship Ventures.  Read more about Venture Capital in the Energy Industry Report

One of LS9’s fundamental products is a biofuel – UltraClean Diesel – which attains an 85% step-down in greenhouse gas emissions, contains no carcinogens, and only trace amounts of sulfur. Moreover, UltraClean Diesel has cleared United States and Brazilian operation standards for on-road use. LS9’s biodiesel product is derived from genetically modifying microorganisms so that the end product has better developed fuel properties.

At present, the company is producing UltraClean Diesel in its pilot plant and it further aims to have demonstration scale output of the product by 2010.  According to Bill Haywood, CEO of LS9, the influx of funding “clearly illustrates the future prospective of LS9 in both the sustainable chemicals and renewable transportation fuels sectors.”  LS9, Inc., the Renewable Petroleum Company, is a privately-held industrial biotechnology company based in South San Francisco, California developing patent-pending UltraClean fuels and sustainable chemicals made with the power of synthetic biology.

LS9 is the market leader in the production of renewable fuels, and is rapidly commercializing and scaling up production capabilities to meet market demands.